Bone Biologics (BBLG) Change in Accured Expenses (2010 - 2025)
Bone Biologics (BBLG) reported Change in Accured Expenses of $84803.0 for Q4 2025, down 53.66% year-over-year from $182985.0 in Q4 2024, and up 220.04% quarter-over-quarter from -$70648.0 in Q3 2025.
Bone Biologics (BBLG) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 16 years of Change in Accured Expenses data on file, last reported at $84803.0 in Q4 2025.
- Change in Accured Expenses for Q4 2025 came in at $84803.0, down 53.66% year-over-year; the trailing twelve-month figure through Dec 2025 was $91025.0 (up 1.39% YoY), and the FY2025 annual result was $91025.0, up 1.39% from the prior year.
- Change in Accured Expenses rose to $84803.0 in Q4 2025 per BBLG's latest filing, from -$70648.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $728839.0 in Q3 2022 and troughed at -$694689.0 in Q4 2022.
- A 5-year average of $24327.9 and a median of $26832.0 in 2021 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses soared 5320.16% in 2022, then slumped 429.37% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at $440121.0 in 2021, then sank by 257.84% to -$694689.0 in 2022, then soared by 130.66% to $213017.0 in 2023, then dropped by 14.1% to $182985.0 in 2024, then slumped by 53.66% to $84803.0 in 2025.
- Business Quant data shows BBLG's Change in Accured Expenses at $84803.0 in Q4 2025, -$70648.0 in Q3 2025, and $155886.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | 84,803.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 84,803.00 |
| Dec 31, 2025 | 84,803.00 |
| Sep 30, 2025 | -70,648.00 |
| Sep 30, 2025 | -70,648.00 |
| Jun 30, 2025 | 155,886.00 |
| Jun 30, 2025 | 155,886.00 |
| Mar 31, 2025 | -79,016.00 |
| Mar 31, 2025 | -79,016.00 |
| Dec 31, 2024 | 182,985.00 |
| Dec 31, 2024 | 182,985.00 |
| Sep 30, 2024 | -41,815.00 |
| Sep 30, 2024 | -41,815.00 |
| Jun 30, 2024 | 85,686.00 |
| Jun 30, 2024 | 85,686.00 |
| Mar 31, 2024 | -137,076.00 |
| Mar 31, 2024 | -137,076.00 |
| Dec 31, 2023 | 213,017.00 |
| Dec 31, 2023 | 213,017.00 |
| Sep 30, 2023 | -664,022.00 |
| Sep 30, 2023 | -664,022.00 |